Considering the functional role of linc-ROR in TGF-β-dependent chemoresistance, the knockdown of ROR using exosomal siRNA delivery to enhance chemotherapy-induced apoptosis and cytotoxicity might be a potential therapy for the treatment of HCC. The gene discussed is LINC-ROR; the disease is hepatocellular carcinoma.